HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Zhibo Chen Selected Research
Zhibo Chen Research Topics
Disease
5
Neoplasms (Cancer)
07/2023 - 01/2017
3
Neuromyelitis Optica (Devic's Disease)
01/2022 - 06/2017
3
Multiple Sclerosis
01/2018 - 10/2017
2
Neuroinflammatory Diseases
01/2024 - 01/2023
2
Inflammation (Inflammations)
01/2022 - 01/2018
2
Arteriosclerosis Obliterans
01/2022 - 01/2018
2
Atherosclerosis
01/2021 - 05/2017
2
Wounds and Injuries (Trauma)
01/2018 - 01/2018
2
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2018 - 01/2017
2
Guillain-Barre Syndrome
10/2017 - 04/2017
2
Autoimmune Diseases (Autoimmune Disease)
07/2017 - 03/2017
2
Neoplasm Metastasis (Metastasis)
01/2017 - 01/2015
1
Liver Neoplasms (Liver Cancer)
07/2023
1
Glioma (Gliomas)
07/2023
1
Asthma (Bronchial Asthma)
02/2023
1
Adenocarcinoma of Lung
01/2023
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2023
1
Lung Neoplasms (Lung Cancer)
01/2023
1
Arteriosclerosis
01/2022
1
Pathologic Constriction (Stenosis)
01/2022
1
Stroke (Strokes)
01/2022
1
Atherosclerotic Plaque (Atheroma)
01/2022
1
Lead Poisoning (Poisoning, Lead)
02/2021
1
Hemorrhage
01/2021
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1
Ischemic Stroke
01/2021
1
Coronary Disease (Coronary Heart Disease)
01/2021
1
Heart Failure
06/2020
1
Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2018
1
Neointima
01/2018
1
Virus Diseases (Viral Diseases)
12/2017
1
Central Nervous System Viral Diseases
12/2017
1
Nervous System Diseases (Neurological Disorders)
12/2017
1
Polymyositis
07/2017
1
Dermatomyositis (Dermatopolymyositis)
07/2017
1
Transverse Myelitis (Necrotizing Myelitis)
03/2017
1
Papillary Thyroid Cancer
01/2017
1
Body Weight (Weight, Body)
01/2017
1
Demyelinating Diseases (Demyelinating Disease)
01/2017
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015
Drug/Important Bio-Agent (IBA)
4
Antioxidants
IBA
02/2021 - 03/2017
4
Uric Acid (Urate)
IBA
02/2021 - 04/2017
4
MicroRNAs (MicroRNA)
IBA
01/2018 - 01/2015
3
Proteins (Proteins, Gene)
FDA Link
07/2023 - 02/2021
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2017
3
Albumins
IBA
01/2022 - 04/2017
2
Antigens
IBA
01/2023 - 01/2018
2
Rituximab (Mabthera)
FDA Link
01/2022 - 01/2018
2
Bilirubin
IBA
02/2021 - 07/2017
2
Thyroid Hormones
IBA
10/2017 - 03/2017
1
Neuroprotective Agents
IBA
01/2024
1
Ethylene Oxide (Oxirane)
IBA
02/2023
1
Messenger RNA (mRNA)
IBA
01/2022
1
Mycophenolic Acid (Cellcept)
FDA Link
Generic
01/2022
1
Circular RNA
IBA
01/2022
1
Globulins
IBA
02/2021
1
Creatinine
IBA
02/2021
1
Urea (Carbamide)
FDA Link
Generic
02/2021
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2021
1
Anticoagulants
IBA
01/2021
1
N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)
IBA
01/2021
1
HDL Lipoproteins
IBA
01/2021
1
Sincalide
FDA Link
01/2018
1
Myelin-Oligodendrocyte Glycoprotein
IBA
01/2018
1
Autoantigens
IBA
01/2018
1
Serum Response Factor
IBA
01/2018
1
Becaplermin (PDGF-BB)
FDA Link
01/2018
1
Atorvastatin (Lipitor)
FDA Link
01/2018
1
myelin oligodendrocyte glycoprotein (35-55)
IBA
01/2018
1
Peptides (Polypeptides)
IBA
01/2018
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
10/2017
1
Triiodothyronine (Liothyronine)
FDA Link
Generic
10/2017
1
Thyroxine (Levothyroxine)
FDA Link
Generic
10/2017
1
Azathioprine (Imuran)
FDA Link
Generic
06/2017
1
Small Untranslated RNA
IBA
05/2017
1
oxidized low density lipoprotein
IBA
05/2017
1
Free Radicals
IBA
04/2017
1
Therapeutic Uses
IBA
01/2017
1
Indicators and Reagents (Reagents)
IBA
01/2017
1
Tissue Inhibitor of Metalloproteinase-2
IBA
01/2015
Therapy/Procedure
2
Therapeutics
01/2023 - 01/2023
2
Transplantation
06/2020 - 01/2017
1
Aftercare (After-Treatment)
07/2023
1
Fecal Microbiota Transplantation
01/2023
1
Radiotherapy
01/2023
1
Surgical Amputation (Amputations)
01/2022
1
Catheters
01/2021
1
Blood Transfusion (Blood Transfusions)
01/2021
1
Heart-Assist Devices
06/2020
1
Intraperitoneal Injections
01/2018